S. Korea open to use of Ebola drug on new coronavirus after full clinical testing - (The Korea Herald via NewsPoints Desk)

  • South Korea will allow the use of Gilead Sciences' remdesivir to treat COVID-19 patients if clinical tests prove the therapy to be safe and effective, as reported in The Korea Herald.

  • "In case of contingencies, we will try to give it emergency use authorization and allow its domestic use," said deputy director Kwon Jun-wook of the Korea Centers for Disease Control and Prevention.

  • Study results recently released by the US National Institute of Allergy and Infectious Diseases showed that hospitalized patients with COVID-19 who received the drug recovered faster than those who received placebo.

  • Gilead is working with three hospitals in South Korea to clinically test the therapy.

To read more NewsPoints articles, click here.